Drug
Tak 101
Tak 101: highest development phase Phase 2, developed by Takeda. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Takeda
Trials
| Drug | Phase | Indication |
|---|---|---|
| TAK-101 NCT04530123 | Phase 2 | Celiac Disease |
Latest
No recent events.
Follow Tak 101 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.